Jan 11, 2023 / 11:00PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Viatris today. From the company, we'll have a presentation from CEO, Michael Goettler, and then we're going to open up to a Q&A session with the broader management team. With that, I'm going to turn the stage over to Michael, and we'll be back post the presentation with some Q&A.
Michael Goettler - Viatris Inc. - CEO & Executive Director
Thank you, Chris. Thanks. All right. Thank you, Chris, and good afternoon, everybody. This is actually our first as Viatris, which was started in November 2020, our first in-person JPMorgan meeting. So it's really, really nice to be back. And obviously, we are extremely proud in the last 2 years and a few months of everything that we've accomplished to get to this point, but more importantly, excited of the path that we have going forward.
Now I am obliged to say something about forward-looking statements. Obviously, we will be making
Viatris Inc at JPMorgan Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers